Ultracentrifuge Market Report 2026

Ultracentrifuge Market Overview

• Ultracentrifuge market size has reached to $1.42 billion in 2025 • Expected to grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 10.5% • Growth Driver: Increasing Prevalence Of Infectious Diseases Is Driving The Growth Of The Ultracentrifuge Market • Market Trend: Automated Gradient Preparation Accelerates Ultracentrifugation Workflows • North America was the largest region in 2025.

What Is Covered Under Ultracentrifuge Market?

An ultracentrifuge is a powerful centrifuge device that separates particles based on size, shape, and density by spinning at very high speeds, often over 100,000 rotations per minute (RPM). It’s primarily used to isolate and purify biological molecules like proteins, nucleic acids, or viruses. This process enables the separation of particles at the molecular level. The main types of ultracentrifuges are desktop centrifuges and floor centrifuges. A desktop centrifuge is a compact, bench-top device used in laboratories for high-speed sample separation, ideal for small-scale tasks and limited-space environments. They are used for several applications, such as molecular biology, biochemistry, and polymer science, and are used by several end-users, including hospitals, biotechnology and pharmaceutical companies, and academic and research institutions.

What Is The Ultracentrifuge Market Growth Forecast?

The ultracentrifuge market size is expected to see rapid growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to rising adoption in precision medicine research, integration with lab automation systems, increasing demand for high-throughput centrifugation, growth in biopharmaceutical production, expansion in polymer and material science applications. Major trends in the forecast period include high-speed molecular separation, automated sample handling, multi-application centrifuge platforms, ai-enhanced protocol optimization, remote monitoring and control.

Global Ultracentrifuge Market Segmentation

1) By Type: Desktop Centrifuge, Floor Centrifuge 2) By Application: Molecular Biology, Biochemistry, Polymer Science 3) By End-User: Hospitals, Biotechnology And Pharmaceutical Companies, Academic And Research Institutions Subsegments: 1) By Desktop Centrifuge: Benchtop Ultracentrifuges, Microcentrifuges, High-Speed Desktop Centrifuges, Refrigerated Desktop Centrifuges 2) By Floor Centrifuge: Large Capacity Floor Centrifuges, Refrigerated Floor Centrifuges, High-Performance Floor Centrifuges, Continuous Flow Floor Centrifuges

What Are The Drivers Of The Ultracentrifuge Market?

The increasing prevalence of infectious diseases is expected to propel the growth of the ultracentrifuge market going forward. Infectious diseases are caused by microorganisms such as bacteria, viruses, fungi, or parasites and can spread through direct contact, contaminated food or water, or insect bites requiring treatment such as antibiotics or antivirals. The growth in the prevalence of infectious diseases is influenced by factors such as climate change, global travel, urbanization, and poor sanitation. Ultracentrifuges separate and purify viral pathogens, help in proper diagnosis and epidemiological tracking and concentrate viral or bacterial components for effective vaccine production, which is critical in reducing infectious disease prevalence. For instance, in March 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, the number of cases rose from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. Additionally, the rate per 100,000 people went up from 2.5 in 2022 to 2.9 in 2023. Therefore, the increasing prevalence of infectious diseases is driving the growth of the ultracentrifuge industry. The growing demand for personalized medicine is expected to propel the growth of the ultracentrifuge market going forward. Personalized medicine refers to an approach to healthcare that tailors medical treatment and interventions to the individual characteristics of each patient. The demand for personalized medicine is increasing due to advancements in genomic technologies, which enable the precise identification of genetic variations and tailored treatments for individuals. Ultracentrifuges enhance personalized medicine by enabling precise separation and analysis of biomolecules, such as proteins, nucleic acids, and extracellular vesicles. They support accurate diagnostics and targeted therapy development, improving patient-specific treatment strategies and overall healthcare outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the ultracentrifuge industry.

Key Players In The Global Ultracentrifuge Market

Major companies operating in the ultracentrifuge market are Beckman Coulter Inc., Thermo Fisher Scientific Inc., Eppendorf AG, Sartorius AG, KUBOTA Corporation, Hettich Instruments, Sigma Laborzentrifugen GmbH, Hitachi Koki Co Ltd, Haier Biomedical, Hunan Xiangyi Laboratory Instrument Development, OHAUS Corporation, BIOBASE Co Ltd, DLAB Scientific, Hanil Scientific Inc., NuAire Inc., QIAGEN N V, Oxford Lab Products, Bio Rad Laboratories Inc., Labnet International Inc., Porter Rayward Scientific, Sichuan Shuke Instruments, Dalong Instruments, Hunan Anjunyan Instruments, Xiangyi Group, LW Scientific, Boekel Scientific, IKA Werke GmbH & Co KG

Global Ultracentrifuge Market Trends and Insights

Major companies operating in the ultracentrifugation market are focusing on developing advanced solutions, such as automated gradient preparation, to enhance throughput and reproducibility. Automated gradient preparation is the process of using a machine to form precise density gradients in centrifuge tubes, reducing manual workload and ensuring consistency between samples. For instance, in April 2025, Beckman Coulter Life Sciences, a US-based provider of laboratory automation and diagnostic systems, launched the OptiMATE Gradient Maker, designed to speed up density gradient ultracentrifugation (DGUC) workflows. The system reduces gradient preparation and centrifugation times, shortening spin cycles from up to 48 hours to less than 5 hours and minimizing manual steps such as sealing and method setup. Its plug-and-play design integrates with existing lab setups and delivers consistent gradients for high-purity viral vector purification workflows like AAV. The intuitive software enables quick operator training in hours rather than days, helping labs improve efficiency and reproducibility in their ultracentrifuge applications.

Regional Outlook

North America was the largest region in the ultracentrifuge market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Ultracentrifuge Market?

The ultracentrifuge market consists of sales of rotors, centrifuge chambers, control panels, sample tubes, and holders. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.